Development of an Automated Chemiluminescent Enzyme Immunoassay for Measuring Thrombopoietin in Human Plasma

• Published in: Diagnostics (Basel) Vol. 12; no. 2; p. 313
• Main Authors: Nishikawa, Yukihiro, Nishida, Shiyo, Kuroda, Keiko, Kashiwagi, Hirokazu, Tomiyama, Yoshiaki, Kuwana, Masataka
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 26-01-2022; MDPI
• Subjects: Antigens; automated; Automation; Bone marrow; chemiluminescent; Enzymes; Gene expression; immune thrombocytopenia; Immunoassay; Medical laboratories; Monoclonal antibodies; Phosphatase; Plasma; Proteins; Thrombocytopenia; thrombopoietin; United States > US; Japan; thrombopoietin; automated; chemiluminescent; thrombocytopenia; immune thrombocytopenia; aplastic anemia; immunoassay
• ISSN: 2075-4418; 2075-4418
• DOI: 10.3390/diagnostics12020313

Plasma thrombopoietin (TPO) measurements help distinguish between different types of thrombocytopenia but are not feasible in routine clinical practice. We developed a fully automated quantitative chemiluminescent enzyme immunoassay (CLEIA) for measuring TPO (TPO-CLEIA), which is a one-step sandwich-type assay. This assay utilizes a mouse monoclonal capture antibody, which has the neutralizing epitope of the interaction between TPO and the TPO receptor, and a newly generated rabbit monoclonal detector antibody. In analytical performance studies, this assay showed good linearity over the measuring range and high sensitivity. The limit of quantification (LoQ) of this assay was 3.4 pg/mL; low TPO concentration values of almost all healthy individuals exceeded the LoQ value. In clinical validation studies, TPO levels obtained from patients with aplastic anemia (AA) significantly increased, whereas those of patients with immune thrombocytopenia (ITP) were normal or slightly increased. The cutoff value for TPO-CLEIA corresponding to the previously reported values was useful for distinguishing between ITP and AA. These results suggest that TPO-CLEIA can quantify human plasma TPO levels with high accuracy and sensitivity and has the potential to facilitate routine clinical measurement of TPO in patients with various types of thrombocytopenia.